Name | Nitroxazepine |
---|---|
Synonyms |
CNU9GY55SI
10-[3-(Dimethylamino)propyl]-2-nitrodibenzo[b,f][1,4]oxazepin-11(10H)-one Dibenz[b,f][1,4]oxazepin-11(10H)-one, 10-[3-(dimethylamino)propyl]-2-nitro- Nitroxazepine |
Description | Nitroxazepine is a tricyclic antidepressant (TCA) for the treatment of depression. Nitroxazepine acts as a serotonin-norepinephrine reuptake inhibitor. |
---|---|
Related Catalog | |
Target |
serotonin-norepinephrine reuptake |
In Vitro | The in vitro effect of Nitroxazepine (Sintamil), as a modulator alone and in combination with hydroxyurea (HU), on cytotoxicity is studied in 16 cases of human chronic myeloid leukemia (CML). The cytotoxicity of the drugs as a function of the exposure dose (HU, 100 μM; Nitroxazepine, 10 μg/mL) and the exposure time (1 h) to the agent is investigated. Cytotoxicity is evaluated as the inhibition of incorporation of [3H-methyl]thymidine in the nucleic acids of CML cells. Cytotoxicity of HU is greatly enhanced (P<0.001) by 1 h exposure of the CML cells to Nitroxazepine. The present data indicate that Nitroxazepine potentiates the cytotoxic activity of HU in CML cells[1]. Nitroxazepine is indicated for the treatment of nocturnal enuresis. Nitroxazepine has similar effects to imipramine, but with certain advantages, such as lower anticholinergic side effects. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 514.3±50.0 °C at 760 mmHg |
Molecular Formula | C18H19N3O4 |
Molecular Weight | 341.361 |
Flash Point | 264.8±30.1 °C |
Exact Mass | 341.137543 |
LogP | 2.41 |
Vapour Pressure | 0.0±1.3 mmHg at 25°C |
Index of Refraction | 1.606 |
Storage condition | 2-8℃ |